Upstart (UPST) Chief Legal Officer executes 10b5-1 option exercise and sale
Rhea-AI Filing Summary
Upstart Holdings insider Scott Darling executed an option exercise and contemporaneous sale under a Rule 10b5-1 plan on 09/17/2025. The filing shows exercise of an employee stock option to acquire 1,000 shares at an exercise price of $13.22 per share, and the sale of 1,000 shares at a weighted average price of $70.0095 per share. After these transactions the reporting person beneficially owned 123,898 shares of common stock. The filing also discloses employee stock options covering a total of 199,527 underlying shares, and that certain shares counted in holdings are restricted stock units subject to vesting.
Positive
- Transaction executed pursuant to a Rule 10b5-1 trading plan, indicating pre-arranged execution
- Significant retained holdings: 123,898 shares beneficially owned after the transactions
- Substantial option exposure remains: options covering 199,527 underlying shares
Negative
- Insider sold 1,000 shares at a weighted average price of $70.0095, reducing common stock holdings from 124,898 to 123,898
- Some holdings are restricted stock units (RSUs) and remain subject to vesting conditions
Insights
TL;DR: Routine insider exercise and sale under a 10b5-1 plan; holdings remain material.
The Form 4 documents a planned exercise of an employee option and an immediate sale of the same number of shares under a Rule 10b5-1 trading plan adopted May 30, 2025. The exercise price was $13.22 and the sale realized a weighted average of $70.0095, representing a material per-share gain relative to exercise price. Post-transaction beneficial ownership remains significant at 123,898 shares, plus options covering 199,527 underlying shares and RSUs subject to vesting. This is a transactional disclosure rather than a signal of changed control or corporate action.
TL;DR: Properly documented 10b5-1 execution; no governance red flags in the filing itself.
The filing states the trades were effected pursuant to a Rule 10b5-1 plan adopted May 30, 2025 and includes the required explanations and signature via power of attorney. The disclosure identifies the reporting person as Chief Legal Officer and provides clear post-transaction holdings and option schedules. There are no indications in this Form 4 of accelerated vesting, related-party transactions, or deviations from standard insider-plan execution.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to buy) | 1,000 | $13.22 | $13K |
| Exercise | Common Stock | 1,000 | $13.22 | $13K |
| Sale | Common Stock | 1,000 | $70.0095 | $70K |
Footnotes (1)
- The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2025. Certain of these securities listed in Column 5 are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.01. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. 1/48 of the shares subject to the option shall vest on January 20, 2023 and at the end of each successive one-month period thereafter, subject to the Reporting Person continuing as a service provider through each such date.
